Nanoscope Therapeutics has achieved significant r
Author: Michael
Citryll has successfully dosed the first patient
Countdown for a Cure provides grant to advance d
Doyle Lokitiyakul, Communications Lead of Public
Alnylam Pharmaceuticals reported new data from it
ProHealth Longevity has introduced a pharmaceutic
Alnylam and its partner Roche will initiate a glo
Immortal Dragons, a US$40 million purpose-driven
SINGAPORE, SG / ACCESS Newswire / August 29, 2025
McKinsey Health Institute report calls for chang